Medicare & Veteran Affairs: Adjustments for duplicate claims
CMS entered into an agreement with the Department of Veterans Affairs (VA), which allows First Coast to recover duplicate...
Articles
Article Type
Category
End stage renal disease (ESRD): Payment for phosphate binders effective January 1
Effective January 1, phosphate binders are paid as a renal dialysis service under Medicare Part B. Read this article to learn...
Syfovre (J2781) removed from injection frequencies system editing
Read this article to learn more about J2781 being removed from injection frequency editing.
Reporting manifestation diagnosis codes
The January Integrated Outpatient Code Editor (IOCE) expands editing related to manifestation diagnosis codes. Read this article...
Prohibition on billing dually eligible individuals enrolled in the Qualified Medicare Beneficiary (QMB) program
This article provides guidance to avoid inappropriately billing Qualified Medicare Beneficiaries (QMBs) for Medicare cost...
Kisunla for monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease
Effective July 2, Medicare will pay for Kisunla for monoclonal antibodies directed against amyloid for the treatment of...
Payment of codes for chemotherapy administration and nonchemotherapy injections and infusion
CMS provided clarification regarding the Medicare guidance relating to complex administration CPT codes 96401-96549. Please read...
Intensive outpatient program (IOP) billing requirements for institutional services
Effective January 1, 2024, IOP services are available for both individuals with mental health conditions and individuals with...
Medicare deductible, coinsurance, and premium rates
CMS has issued the 2025 deductibles, coinsurance, and premium rates for beneficiaries covered through the Medicare fee-for...
Reciprocal billing and fee-for-time compensation arrangements (formerly locum tenens arrangements)
The requirements for the submission of claims under reciprocal billing and fee-for-time compensation arrangements are the same...